These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 6975438

  • 1. High-dose methotrexate in osteogenic sarcoma.
    Jaffe N, Link MP, Cohen D, Traggis D, Frei E, Watts H, Beardsley GP, Abelson HT.
    Natl Cancer Inst Monogr; 1981 Apr; (56):201-6. PubMed ID: 6975438
    [Abstract] [Full Text] [Related]

  • 2. Selected applications of methotrexate alone and in combination in osteosarcoma.
    Pratt CB.
    Cancer Treat Rep; 1981 Apr; 65 Suppl 1():107-11. PubMed ID: 6976828
    [Abstract] [Full Text] [Related]

  • 3. Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7).
    Rosen G, Nirenberg A, Caparros B, Juergens H, Kosloff C, Mehta BM, Marcove RC, Huvos AG.
    Natl Cancer Inst Monogr; 1981 Apr; (56):213-20. PubMed ID: 6946291
    [Abstract] [Full Text] [Related]

  • 4. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
    Juergens H, Kosloff C, Nirenberg A, Mehta BM, Huvos AG, Rosen G.
    Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
    [Abstract] [Full Text] [Related]

  • 5. High-dose methotrexate with citrovorum factor in osteogenic sarcoma--progress report II.
    Jaffe N, Frei E, Traggis D, Cassady JR, Watts H, Filler RM.
    Cancer Treat Rep; 1977 Jul; 61(4):675-9. PubMed ID: 301780
    [Abstract] [Full Text] [Related]

  • 6. Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputation.
    Rosenburg SA, Chabner BA, Young RC, Seipp CA, Levine AS, Costa J, Hanson TA, Head GC, Simon RM.
    Cancer Treat Rep; 1979 May; 63(5):739-51. PubMed ID: 313245
    [Abstract] [Full Text] [Related]

  • 7. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
    Jaffe N, Carrasco H, Raymond K, Ayala A, Eftekhari F.
    Cancer; 2002 Nov 15; 95(10):2202-10. PubMed ID: 12412175
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of osteogenic sarcoma. II. Aggressive resection of pulmonary metastases.
    Rosenburg SA, Flye MW, Conkle D, Seipp CA, Levine AS, Simon RM.
    Cancer Treat Rep; 1979 May 15; 63(5):753-6. PubMed ID: 287554
    [Abstract] [Full Text] [Related]

  • 11. Phase II study of low-dose methotrexate in advanced osteosarcoma followed by escalation after disease progression: a study of the Soft Tissue and Bone Sarcoma Group of the European Organization for Research on Treatment of Cancer.
    Wagener DJ, van Oosterom AT, Mulder JH, Somers R, Mouridsen HT, Cortes Funes H, Thomas D, Sylvester R.
    Cancer Treat Rep; 1986 May 15; 70(5):615-8. PubMed ID: 3458532
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Adjuvant chemotherapy for osteosarcoma at the Singapore General Hospital.
    Khor TH, Chua EJ, Tan BC, Chia KB.
    Singapore Med J; 1983 Apr 15; 24(2):95-8. PubMed ID: 6577611
    [No Abstract] [Full Text] [Related]

  • 14. [Preoperative and postoperative chemotherapy of osteogenic sarcoma of the limbs in children].
    Muñoz Villa A, Ocete G, Aymerich ML, Maldonado S, Otheo E, Calvo M, Amaya J.
    Med Clin (Barc); 1996 Jun 29; 107(5):161-4. PubMed ID: 8758673
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical observations on the use of high-dose methotrexate treatment in osteogenic sarcoma (author's transl)].
    Kotz R, Leber H, Ramach W, Arbes H, Wolf A.
    Wien Klin Wochenschr; 1977 Jul 15; 89(14):474-9. PubMed ID: 70889
    [Abstract] [Full Text] [Related]

  • 17. The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue.
    Zelcer S, Kellick M, Wexler LH, Gorlick R, Meyers PA.
    Pediatr Blood Cancer; 2008 Jun 15; 50(6):1176-80. PubMed ID: 18266225
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.